Latest AI and machine learning research in genetics for healthcare professionals.
Motivation: Models deployed for genomic prediction of diseases perform unevenly across populations, limiting clinical utility. Two factors drive this limitation: large imbalances in sample availability across ancestry groups and non-stationarity of genotype-phenotype effect sizes across the ancestry continuum. While tabular foundation models with in-context learning (ICL) have shown strong sample ...
Background: Non-invasive diagnosis, reliable recurrence surveillance remain critical unmet needs in gliomas. Glioma induces profound systemic immune alterations despite its anatomical confinement to the central nervous system. Circulating immune cells, particularly monocytes, are key mediators of tumor-host crosstalk and may retain tumor-induced transcriptional imprints. However, their potential c...
Machine learning (ML)- and artificial intelligence (AI)-based aging clocks are increasingly used to quantify physiological and molecular aging from om...
The availability of multiple commercial short-read sequencing platforms necessitates systematic cross-platform performance comparisons, particularly f...
Cancer is a disease of the genome, in which somatic mutations and copy-number alterations determine tumour identity, clinical behaviour, and response ...
Background Bacterial fitness is shaped by interactions between genome variation and environmental context, yet how these interactions determine its pr...
RNA binding proteins (RBPs) regulate the life cycle of an mRNA, often through RBP-RNA interactions. This life cycle includes splicing, whereby the int...
Gene fusions are clinically relevant genomic alterations and key cancer biomarkers. Their computational detection remains dominated by alignment-based...
The pioneer factor hypothesis posits that specialized transcription factors access nucleosomal DNA to enable binding of secondary factors, implying a ...
We present ModCRE-NN, a machine-learning framework and server for predicting transcription-factor (TF) DNA-binding motifs through the integration of s...
Oncologists are increasingly relying on multiple modalities to model the complexity of diseases. Within this landscape, transcriptomic and epigenetic ...
Somatic variant calling, the identification of mutations in non-germline cells acquired over an individual's lifetime, is critical for studying diseas...
Background: Bioinformatic tools often require the prediction of protein-coding genes to make inferences about prokaryotic genomes. Typically, the gene...
Noncoding regulatory variants contribute to colorectal cancer (CRC) susceptibility, yet their functional interpretation remains difficult.This is main...
Precision medicine aims to advance our ability from a "one-size-fits-all" approach to personalized and predictive healthcare across diverse population...
Objective: To systematically evaluate pathway-informed polygenic risk score (PRS) strategies and determine which approaches most effectively leverage ...
Background: Polygenic risk scores (PRS) for coronary artery disease (CAD) are associated with cardiovascular events, but the relationship between inhe...
Understanding and modeling how a single human genome concurrently encodes gene regulatory programs for thousands of cell types remains a central chall...
T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive pediatric malignancy characterized by complex heterogeneity across multiple molecular ...
Tumour-educated platelets (TEPs) carry cancer-type-specific RNA signatures accessible through whole-blood RNA sequencing, but systematic multi-algorit...